MiR-532-3p inhibits metastasis and proliferation of non-small cell lung cancer by targeting FOXP3.

CONCLUSIONS: Our research discovered the suppressive function of miR-532-3p in NSCLC by targeting FOXP3, revealing that miR-532-3p/FOXP3 axis might be a potential therapeutic target for the treatment of NSCLC. PMID: 31983096 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31983096?dopt=Abstract

Source: Journal of B.U.ON. - January 28, 2020 Category: Cancer & Oncology Tags: J BUON Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Websites